Similar articles

• A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.

  Möller HJ, Kasper S, Müller H, Kissling W, Fuger J, Ruhrmann S. Möller HJ, et al. Pharmacopsychiatry. 1995 Nov;28(6):249-52. doi: 10.1055/s-2007-979611. Pharmacopsychiatry. 1995. PMID: 8773291 Clinical Trial.
• Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.

  Palomäki H, Kaste M, Berg A, Lönnqvist R, Lönnqvist J, Lehtihalmes M, Hares J. Palomäki H, et al. J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):490-4. doi: 10.1136/jnnp.66.4.490. J Neurol Neurosurg Psychiatry. 1999. PMID: 10201422 Free PMC article. Clinical Trial.
• Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.

  Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J; MIND-IT investigators. Honig A, et al. Psychosom Med. 2007 Sep-Oct;69(7):606-13. doi: 10.1097/PSY.0b013e31814b260d. Epub 2007 Sep 10. Psychosom Med. 2007. PMID: 17846258 Clinical Trial.
• SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.

  Kent JM. Kent JM. Lancet. 2000 Mar 11;355(9207):911-8. doi: 10.1016/S0140-6736(99)11381-3. Lancet. 2000. PMID: 10752718 Review.
• [Mianserin: pharmacology and clinical aspects of an effective antidepressive agents].

  Demling J. Demling J. Fortschr Med. 1993 Nov 10;111(31):497-500. Fortschr Med. 1993. PMID: 8276338 Review. German.